Virtus ETF Advisers LLC Praxis Precision Medicines, Inc. Transaction History

Virtus ETF Advisers LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 12, 2022	SELL	$1.75 - $11.34 $14,901 - $96,560	-8,515 Closed	0 $0
Q1 2022 May 16, 2022	SELL	$10.21 - $20.29 $5,207 - $10,347	-510 Reduced 5.65%	8,515 $87,000
Q4 2021 Feb 14, 2022	SELL	$16.76 - $22.99 $20,698 - $28,392	-1,235 Reduced 12.04%	9,025 $178,000
Q3 2021 Nov 15, 2021	SELL	$13.15 - $22.56 $7,114 - $12,204	-541 Reduced 5.01%	10,260 $190,000
Q2 2021 Aug 10, 2021	BUY	$18.28 - $33.05 $197,442 - $356,973	10,801 New	10,801 $197,000

75K

Ticker PRAX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 45,576,100
Market Cap $2.18B
Description
Praxis Precision Medicines, Inc., a clinical-stage biopharmaceutical company, develops therapies for central nervous system disorders characterized by neuronal imbalance. Its lead product candidates include PRAX-114, an extrasynaptic-preferring GABAA receptor positive allosteric modulator that is in Phase IIa clinical trial for the treatment of ...

Get notified when there are updates to the investment portfolio of Virtus ETF Advisers LLC, based on Form 13F filings with the SEC.

Stay updated on Virtus ETF Advisers LLC with notifications on news.